Our perception of the mast cell from Paul Ehrlich to now

被引:141
作者
Beaven, Michael A. [1 ]
机构
[1] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
Adaptive immunity; Autoimmune diseases; Innate immunity; Mast cell; Paul Ehrlich; FC-EPSILON-RI; AFFINITY IGE RECEPTOR; TOLL-LIKE RECEPTOR-2; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CATHELICIDIN ANTIMICROBIAL PEPTIDE; SLOW-REACTING SUBSTANCE; MEDIATOR RELEASE; CHEMICAL FACTORS; INNATE IMMUNITY; GROWTH-FACTOR;
D O I
10.1002/eji.200838899
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
just over a century ago Paul Ehrlich received the Nobel Prize for his studies of immunity. This review describes one of his legacies, the histochemical description of the mast cell, and the research that has ensued since then. After a long period of largely descriptive studies, which revealed little about the biological role of the mast cell, the field was galvanized in the 1950s by the recognition that the mast cell was the main repository of histamine and a key participant in anaphylactic reactions. Although the mast cell was long-viewed in these terms, recent research has now shown that the mast cell also plays a key role in innate and adaptive immune responses, autoimmune disease, and possibly tissue homeostasis by virtue of its expression of a diverse array of receptors and biologically active products. in addition, the responsiveness of mast cells to immunological and pathological stimulants is highly modulated by the tissue cytokine environment and by synergistic, or inhibitory, interactions among the various mast cell receptor systems. This once enigmatic cell of Paul Ehrlich has proved to be both adaptable and multifunctional.
引用
收藏
页码:11 / 25
页数:15
相关论文
共 194 条
[1]   MOLECULAR-CLONING OF MAST-CELL GROWTH-FACTOR, A HEMATOPOIETIN THAT IS ACTIVE IN BOTH MEMBRANE-BOUND AND SOLUBLE FORMS [J].
ANDERSON, DM ;
LYMAN, SD ;
BAIRD, A ;
WIGNALL, JM ;
EISENMAN, J ;
RAUCH, C ;
MARCH, CJ ;
BOSWELL, HS ;
GIMPEL, SD ;
COSMAN, D ;
WILLIAMS, DE .
CELL, 1990, 63 (01) :235-243
[2]   The β subunit of the type I Fcε receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells [J].
Andrásfalvy, M ;
Péterfy, H ;
Tóth, G ;
Matkó, J ;
Abramson, J ;
Kerekes, K ;
Vámosi, G ;
Pecht, I ;
Erdei, A .
JOURNAL OF IMMUNOLOGY, 2005, 175 (05) :2801-2806
[3]   Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES [J].
Aoki, M ;
Pawankar, R ;
Niimi, Y ;
Kawana, S .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2003, 130 (03) :216-223
[4]   Mast cell-fibroblast interactions: Human mast cells as source and inducers of fibroblast and epithelial growth factors [J].
Artuc, M ;
Steckelings, UM ;
Henz, BM .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (03) :391-395
[5]  
Austen K Frank, 2005, Novartis Found Symp, V271, P166
[6]  
BABA T, 1976, J IMMUNOL, V116, P112
[7]   IGE-INDUCED HISTAMINE-RELEASE FROM RAT BASOPHILIC LEUKEMIA-CELL LINES - ISOLATION OF RELEASING AND NON-RELEASING CLONES [J].
BARSUMIAN, EL ;
ISERSKY, C ;
PETRINO, MG ;
SIRAGANIAN, RP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (04) :317-323
[8]  
BAZIN H, 1974, IMMUNOLOGY, V26, P713
[9]  
Beaven M A, 1978, Monogr Allergy, V13, P1
[10]  
BEAVEN MA, 1984, J BIOL CHEM, V259, P7129